Clinical Trial Update: Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Unmethylated Gene Promoter Status [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluated cilengitide in combination with temozolomide and radiation therapy for newly diagnosed glioblastoma with unmethylated MGMT pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Temozolomide (Temozolomide)
• cilengitide (cilengitide)

Snippet

Sponsor: EMD Serono | Conditions: Glioblastoma | Phase 2 | Status: COMPLETED | Results posted: 2014-12-08